Last reviewed · How we verify
Subretinally injected RetinoStat
At a glance
| Generic name | Subretinally injected RetinoStat |
|---|---|
| Also known as | OXB-201 |
| Sponsor | Oxford BioMedica |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |